Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011

Eurosurveillance

Volumn 16, Issue 33, 2011, Pages

  Steinmann, J ^a   Kaase, M ^b   Gatermann, S ^b   Popp, W ^a   Steinmann, E ^c   Damman, M ^a   Paul, A ^a   Saner, F ^a   Buer, J ^a   Rath, P M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CARBAPENEMASE; IMIPENEM; KLEBSIELLA PNEUMONIAE CARBAPENEMASE 2; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG; VANCOMYCIN; VERONA INTEGRON ENCODED METALLO BETA LACTAMASE 1;

ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; DNA FINGERPRINTING; EPIDEMIC; FEMALE; GENOTYPE; GERMANY; HOST PATHOGEN INTERACTION; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; RETROSPECTIVE STUDY; REVIEW;

EID: 80052599300     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Paterson DL, Bonomo RA. Extended-spectrum betalactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
2. Kang HY, Jeong YS, Oh JY, Tae SH, Choi CH, Monn DC, et al. Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea. J Antimicrob Chemother. 2005;55(5):639-44.
3. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA. 2008;300(24):2911-3.
4. Vatopoulos A. High rates of metallo-beta-lactamaseproducing Klebsiella pneumoniae in Greece--a review of the current evidence. Euro Surveill. 2008;13(4):8023. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8023
5. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009;53(8):3365-70.
6. Leavitt A, Carmeli Y, Chmelnitsky I, Goren MG, Ofek I, Navon-Venezia S. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob Agents Chemother. 2010;54(7):3002-6.
7. Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009;30(10):972-6.
8. Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother. 2009;53(5):1868-73.
9. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29(12):1099-106.
10. Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, et al. An outbreak of infection due to betalactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2010;50(3):364-73.
11. Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980;289(1036):321-31.
12. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 2010;15(46):pii=19711. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19711
13. Moellering RC Jr. NDM-1--a cause for worldwide concern. N Engl J Med. 2010;363(25):2377-9.
14. Naas T, Nordmann P. OXA-type beta-lactamases. Curr Pharm Des. 1999;5(11):865-79.
15. Wendt C, Scht S, Dalpke AH, Konrad M, Mieth M, Trierweiler-Hauke B, et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis. 2010;29(5):563-70.
16. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology. 9th ed, Herndon: ASM Press, 2007.
17. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints. EUCAST. [Accessed 20 Jan 2011]. Available from: http://www.eucast.org/clinical_breakpoints
18. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement. CLSI document M100-S19. Wayne: CLSI; 2009. p. 136-9.
19. Pitout JD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa producing metallo-betalactamases in a large centralized laboratory. J Clin Microbiol. 2005;43(7):3129-35.
20. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol. 2009.;47(6):1631-9.
21. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151-61.
22. Juan C, Beceiro A, Gutiérez O, Albertí·S, Garau M, Péez JL,et al. Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain. Antimicrob Agents Chemother. 2008;52(10):3589-96.
23. Poirel L, Hitier C, TolV, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48(1):15-22.
24. Tenover FC, Gay EA, Frye S, Eells SJ, Healy M, McGowan JE Jr. Comparison of typing results obtained for methicillinresistant Staphylococcus aureus isolates with the DiversiLab system and pulsed-field gel electrophoresis. J Clin Microbiol. 2009;47(8):2452-7.
25. Marchaim D, Chopra T, Pogue JM, Perez F, Hujer AM, Rudin S, et al. Outbreak of colistin-resistant, carbapenem-resistent Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother. 2011;55(2):593-9.
26. Giakkoupi P, Pappa O, Polemis M, Vatopoulos AC, Miriagou V, Zioga A, et al. Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases. Antimicrob Agents Chemother. 2009;53(9):4048-50.
27. Zioga A, Miriagou V, Tzelepi E, Douzinas E, Tsakiri M, Legakis NJ, et al. The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2. Int J Antimicrob Agents. 2010;36(2):190-1.
28. Österblad M, Kirveskari J, Koskela S, Tissari P, Vuorenoja K, Hakanen AJ, et al. First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009. Euro Surveill. 2009;14(40):pii=19349. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19349
29. Samuelsen Ø, Naseer U, Tofteland S, Skutlaberg DA, Onken A, Hjetland R, et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmidmediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother. 2009;63(4):654-8.
30. Hasman H, Fjeldsø-Nielsen H, Lausten T, Berthelsen BG. Isolation of a VIM-1 metallo-ß-lactamse-producing Klebsiella pneumoniae isolate in Denmark. Int J Antimicrob Agents. 2010;36(5):468-9.
31. F, Ruppé·E, Giakkoupi P, Wildenberg L, Lucet J, Vatopoulos A, et al. Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain. Euro Surveill. 2010;15(1):pii=19457. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19457
32. Kassis-Chikhani N, Saliba F, Carbonne A, Neuville S, Decre D, Sengelin C, et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill. 2010;15(46):pii=19713. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19713
33. Wilson AP, Smyth D, Moore G, Singleton J, Jackson R, Gant V, et al. The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care untis in two hospitals. Crit Care Med. 2011;39(4):651-8.
34. Vaux S, Carbonne A, Thiolet JM, Jarlier V, Coignard B, RAISIN and Expert Laboratories Groups. Emergence of carbapenamseproducing Enterobacteriaceae in France, 2004 to 2011. EuroSurveill. 2011;16(22):pii=19880. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19880
35. Carbonne A, Thiolet JM, Fournier S, Fortineau N, Kassis- Chikhani N, Boytchev I, et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill. 2010;15(48):pii=19734. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19734